ABHD16A
Basic information
Region (hg38): 6:31686955-31703356
Previous symbols: [ "BAT5" ]
Links
Phenotypes
GenCC
Source:
- spastic paraplegia 86, autosomal recessive (Moderate), mode of inheritance: AR
- spastic paraplegia 86, autosomal recessive (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 86, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 34489854; 34587489; 34866177 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABHD16A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 30 | 36 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 1 | 32 | 9 | 1 |
Variants in ABHD16A
This is a list of pathogenic ClinVar variants found in the ABHD16A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-31687253-G-A | Inborn genetic diseases | Uncertain significance (Jul 12, 2022) | ||
6-31687518-G-A | Inborn genetic diseases | Uncertain significance (Aug 02, 2022) | ||
6-31687532-C-T | Inborn genetic diseases | Uncertain significance (Apr 01, 2024) | ||
6-31687660-C-T | Inborn genetic diseases | Uncertain significance (Feb 27, 2024) | ||
6-31687687-G-A | Inborn genetic diseases | Uncertain significance (Jun 03, 2022) | ||
6-31687723-A-G | ABHD16A-related disorder | Uncertain significance (Feb 07, 2023) | ||
6-31687731-TA-T | Autosomal recessive complex spastic paraplegia | Likely pathogenic (Sep 30, 2021) | ||
6-31687735-T-C | Inborn genetic diseases | Likely benign (Aug 12, 2021) | ||
6-31687744-G-C | Inborn genetic diseases | Uncertain significance (Jun 17, 2022) | ||
6-31687890-C-G | Inborn genetic diseases | Uncertain significance (Oct 13, 2023) | ||
6-31687893-G-A | Inborn genetic diseases | Uncertain significance (Mar 18, 2024) | ||
6-31688041-C-T | Complex hereditary spastic paraplegia • Spastic paraplegia 86, autosomal recessive | Pathogenic (Feb 09, 2022) | ||
6-31688077-C-T | Inborn genetic diseases | Uncertain significance (May 01, 2022) | ||
6-31688078-G-A | Spastic paraplegia | Uncertain significance (Jul 01, 2021) | ||
6-31688237-C-CCACG | Likely benign (Feb 01, 2024) | |||
6-31688737-C-T | Benign (Jul 01, 2024) | |||
6-31688740-G-A | Likely benign (Feb 01, 2024) | |||
6-31688747-A-C | Spastic paraplegia 86, autosomal recessive • Spastic paraplegia | Uncertain significance (Jul 01, 2021) | ||
6-31689027-G-A | Inborn genetic diseases | Uncertain significance (Feb 27, 2024) | ||
6-31690086-C-T | Inborn genetic diseases | Uncertain significance (Mar 19, 2024) | ||
6-31691587-G-A | Spastic paraplegia 86, autosomal recessive | Pathogenic (Feb 09, 2022) | ||
6-31691667-C-T | Spastic paraplegia | Uncertain significance (Jul 01, 2021) | ||
6-31691671-G-A | Inborn genetic diseases | Uncertain significance (May 09, 2023) | ||
6-31691680-A-T | Inborn genetic diseases | Uncertain significance (Apr 20, 2024) | ||
6-31691890-G-A | Inborn genetic diseases | Uncertain significance (Feb 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABHD16A | protein_coding | protein_coding | ENST00000395952 | 20 | 16496 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.473 | 0.527 | 125719 | 0 | 29 | 125748 | 0.000115 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.48 | 207 | 335 | 0.619 | 0.0000204 | 3580 |
Missense in Polyphen | 55 | 110.56 | 0.49747 | 1186 | ||
Synonymous | 1.02 | 110 | 124 | 0.884 | 0.00000659 | 1116 |
Loss of Function | 4.63 | 9 | 41.0 | 0.220 | 0.00000232 | 412 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000212 | 0.000210 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.0000547 | 0.0000544 |
Finnish | 0.000417 | 0.000416 |
European (Non-Finnish) | 0.0000989 | 0.0000967 |
Middle Eastern | 0.0000547 | 0.0000544 |
South Asian | 0.0000331 | 0.0000327 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.56
Haploinsufficiency Scores
- pHI
- 0.253
- hipred
- Y
- hipred_score
- 0.747
- ghis
- 0.511
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abhd16a
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; immune system phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- monoacylglycerol catabolic process;prostaglandin catabolic process
- Cellular component
- integral component of membrane
- Molecular function
- lysophospholipase activity;protein binding;acylglycerol lipase activity